​​​320 Santa Fe Drive, Suite 211

Encinitas, CA 92024



​​​​​​​​​California HealthSpan Institute      


Akishita M et al. Association of plasma dehydroepiandrosterone-sulfate levels with endothelial function in postmenopausal women with coronary risk factors. Hypertens Res. 2008 Jan;31(1):69-74

Alhaj HA et al. Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study. Psychopharmacology (Berl). 2005 Oct 18;1-11

Alkatib AA et al. A systematic review and meta-analysis of randomized placebo-controlled trial of DHEA treatment effects on quality of life in women with adrenal insufficiency. J Clin Endocrinol Metab. 2009 Oct;94(10):3676-81

Bauer ME et al. Stress, glucocorticoids and aging of the immune system. Stress. 2005 Mar;8(1):69-83

Bednarek-Tupikowska G et al. The correlations between endogenous dehydroepiandrosterone sulfate and some atheroschlerosis risk factors in premenopausal women. Med Sci Minot. 2008 Jan;14(10):CR3741

Brignardello E et al. Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients. Diabetes care. 2007 Nov;30(11):2922-7

Cappola AR et al. Trajectories of dehydroepiandrosterone sulfate predict mortality in order older adults: the cardiovascular health study. J Gerontol A Biol Sci Med Sci. 2009 Dec;64(12):1268-74

Dhatariya K et al. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabets. 2005 Mar;54(3):765-9

Enomoto M et al. Serum dehydroepiandrosterone sulfate levels predict longevity in men: 27-year follow-up study in a community-based cohort (Tanushimaru study). J Am Geriatr Soc. 2008 Jun;56(6):994-8

Fukui M et al. Serum dehydroepiandrosterone sulfate concentration and carotid atherosclerosis in men with type 2 diabetes.  Atherosclerosis 2005 Aug;181(2):339-44

Hampl et al. Steroids and thermogenesis. Physiol Res. 2005 May 24

Herman WA et al. Could serum DHEA and DHEAS levels be good risk predictors of metabolic syndrome and osteoporosis in the population of aging men? Pol Merkur Lekarski. 2009 Sep;27(159):197-201

Jankowski CM et al. Effects of DHEA Replacement Therapy on Bone Mineral Density in Older Adults: A Randomized, Controlled Trial. J Clin Endocrinol Metab. 2006 May 30

Jankowski EA et al. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation. 2006 Oct 24;114(17):1829-37

Jian ZW et al. Relationship between dehydroepiandrosterone and arteriosclerosis in premenopausal and postmenopausal women. Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jun;28)6):942-3

Labrie F et al. Is dehydroepiandrosterone a hormone?  J Endocrinol 2005 Nov;187(2):169-96

Maes M et al. Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in chronic fatigue syndrome(CFS): relevance for the inflammatory response in CFS. Neuro Endocrinol LEtt. 2005 Oct;26(5):487-92

Martina V et al. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects.  Clin Endocrinol (Oxf). 2006 Mar;64(3):260-4

Morgan CA 3rd et al. Relationships among plasma dehydroepiandrosterone and dehydroepiandrosteronesulfate, cortisol, symptoms of dissociation, and objective performance in humans exposed to underwater navigation stress. Biol Psychiatry. 2009 Aug 15;66(4):334-40

Nordmark G et al. Effects of dehydroepiandrosterone supplement on health-related qulity of life in glucocorticoid treated females with system lupus erythematosus. Autoimmunity. 2005 Nov;38(7):531-40

Rabijewski M et al. Positive effects of DHEA therapy on insulin resistance and lipids in men with angiographically verified coronary artery heart disease. Prelim study. Endokrynol Pol. 2005;56(6):904-10

Ritsner M et al. Alterations in DHEA metabolism in schizophrenia: Two-month case-control study. Eur Neuropsychopharmacol. 2006 Feb;16(2):137-46

Savastano S et al. Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women. J Endocrinol. 2005 Jun;28(6):509-15

Schmidt M et al. Inflammation and sex hormone metabolism. Ann N Y Acad Sci. 2006 Jun;1069:236-46

Severi G et al. Circulating steroid hormones and the risk of prostate cancer. Epidemiol Biomarkers PRev. 2006 Jan;15(1):86-91

Shilkaitis A et al. Dehydroepiandrosterone inhibits the progression phase of mammary cardinogensis by inducing cellular senescence via a ;16-dependent but p53-independent mechanism. Breast Cancer Res. 2005;7(6):R1132-40

Tellez N et al. Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone. Mult Scler. 2006 Aug;12(4):487-94

Von Muhlen et al. The Dehydroepiandrosterone and Wellness (DAWN) study: research design and methods. Contemp Clin Trial. 2007 Feb;28(2):153-68

Yang SC et al. Interactive effect of an acute bout of resistance exercise and dehydroepiandrosterone administration on glucose tolerance and serum lipids in middle-aged women. Chin J Physiol. 2005 Mar 31;48(1):23-9

​​​​​​​​​​​​The Trusted Source for Preventive / Regenerative ​Medicine